Patricia M LoRusso

25PUBLICATIONS
250CO-AUTHORS
Molecular targetsAutoimmunityChemotherapyCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jun 10, 2026
Brigimadlin Versus Doxorubicin in Advanced Dedifferentiated Liposarcoma: Efficacy, Safety and Translational Data from Brightline-1, a Randomized Phase 2/3 Trial.

|May 23, 2026
Safety and Efficacy of HexaBody-DR5/DR5 in Malignant Solid Tumors: Phase 1/2a Results and Translational Insights Into Observed Hepatotoxicity.

|Jan 08, 2026
From Biology to Bedside: Challenges and Strategies in Developing Combination Cancer Therapies in Early-Phase Trials.

Niamh Coleman, R Donald Harvey, David S Hong

|Oct 02, 2025
FDA-AACR Strategies for Optimizing Dosages for Oncology Drug Products: Selecting Dosages for First-in-Human Trials.

Hao Zhu, Alex N Phipps, Ying Yuan

|Oct 02, 2025
FDA-AACR Strategies for Optimizing Dosages for Oncology Drug Products: Early-Phase Trials Using Innovative Trial Designs and Biomarkers.

Olanrewaju O Okusanya, Gabriela I Patilea-Vrana, Anthony Sireci

|Oct 02, 2025
FDA-AACR Strategies for Optimizing Dosages for Oncology Drug Products: Selecting Optimized Dosages for Registrational Trials.

Stacy S Shord, Cong Chen, Jin Y Jin

Pageof 5

Frequent Collaborators

3 joint publications

Erika Hamilton

3 joint publications

Jiang Liu

3 joint publications

Jayesh Desai

3 joint publications

Scott Boerner